Parkinson's Drug Patent Ax In Del. Helps Mylan Win In Vt.

By Dani Kass (June 8, 2021, 10:18 PM EDT) -- A Delaware federal judge's invalidation of a patent covering UCB Inc.'s Parkinson's disease treatment Neupro was invoked Tuesday in Vermont federal court to help Mylan beat patent litigation over its generic version of the drug.

U.S. District Judge Christina Reiss issued a final judgment on UCB's infringement suit against Vermont-based Mylan Technologies Inc. at the request of the parties, narrowly avoiding a bench trial that had been set for mid-July.

Third Circuit Judge Kent A. Jordan, who had overseen UCB's suit in Delaware against Actavis Laboratories, had invalidated one of the two patents asserted against Mylan, finding the claims obvious and...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!